Amerika Serikat - Inggris - NLM (National Library of Medicine)

bionpharma inc. - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions ( 6.2)]. risk summary the limited available data with desloratadine in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was

Amerika Serikat - Inggris - NLM (National Library of Medicine)

rebel distributors corp - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - clarinex is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 2 years of age and older. clarinex is indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 6 months of age and older. clarinex is indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 6 months of age and older. clarinex tablets 5 mg are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients, or to loratadine. there is no information to indicate that abuse or dependency occurs with clarinex tablets.

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - desloratadine 5 mg - film-coated tablet - 5 mg - desloratadine 5 mg - desloratadine

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - desloratadine 0,5 mg/ml - oral solution - 0,5 mg/ml - desloratadine 0.5 mg/ml - desloratadine

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - desloratadine 5 mg - film-coated tablet - 5 mg - desloratadine 5 mg - desloratadine

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka d.d. novo mesto d.d. - desloratadine 5 mg - film-coated tablet - 5 mg - desloratadine 5 mg - desloratadine

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - desloratadine 2,5 mg - orodispersible tablet - 2,5 mg - desloratadine 2.5 mg - desloratadine

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - desloratadine 5 mg - orodispersible tablet - 5 mg - desloratadine 5 mg - desloratadine

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - desloratadine 0,5 mg/ml - oral solution - 0,5 mg/ml - desloratadine 0.5 mg/ml - desloratadine

Israel - Inggris - Ministry of Health

organon pharma israel ltd., israel - desloratadine - tablets - desloratadine 5 mg - desloratadine - desloratadine - aerius tablet is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with:- allergic rhinitis - urticaria